copyright
du
et
al
openaccess
articl
distribut
term
creativ
common
attribut
licens
cc
permit
unrestrict
use
distribut
reproduct
medium
provid
origin
author
sourc
credit
twolevel
princip
compon
predictor
propos
base
princip
compon
analysi
pca
approach
use
quantit
analyz
variou
compound
peptid
function
potenti
becom
use
drug
one
level
deal
physicochem
properti
drug
molecul
level
deal
structur
fragment
predictor
selflearn
feedback
featur
automat
improv
accuraci
anticip
becom
use
tool
time
provid
variou
use
clue
process
drug
develop
fast
develop
computeraid
drug
design
cadd
current
number
drug
design
approach
develop
sever
comput
softwar
pack
avail
speed
discoveri
new
chemic
biolog
drug
effici
econom
procedur
howev
far
still
perfect
theori
ideal
technolog
faultless
softwar
tool
guarante
complet
success
design
drug
due
complic
interact
medicin
drug
biolog
target
factor
paramet
may
affect
bioactiv
drug
structur
drug
also
biolog
target
coenzym
interact
environ
princip
compon
analysi
pca
use
tool
wide
use
chemistri
biolog
environ
mani
field
social
scienc
pca
approach
also
use
drug
design
mani
year
tradit
pca
singl
level
one
direct
predict
analysi
techniqu
describ
follow
equat
x
k
physicochem
paramet
ith
molecul
k
coeffici
molecular
paramet
w
bioactiv
ith
molecul
bioactiv
w
could
logarithm
ic
pic
logic
bind
free
energi
drug
receptor
coeffici
k
paramet
solv
linear
equat
train
set
drug
candid
paramet
coeffici
k
use
predict
bioactiv
design
newli
synthes
drug
compound
k
total
number
molecular
paramet
current
hundr
even
thousand
molecular
paramet
avail
drug
design
howev
certain
drugreceptor
interact
system
paramet
equal
import
actual
mani
paramet
may
caus
correl
problem
pca
techniqu
principl
compon
select
describ
bioactiv
drug
molecul
predict
bioactiv
drug
candid
present
studi
improv
princip
compon
analysi
method
socal
twolevel
princip
compon
analysi
propos
deal
extrem
complex
huge
amount
paramet
drug
design
discoveri
predictor
st
level
deal
physicochem
properti
drug
molecul
nd
level
deal
fragment
molecular
structur
propos
twolevel
model
significantli
enhanc
predict
power
also
yield
use
inform
indepth
analysi
accord
chou
rule
wide
use
mani
investig
see
eg
develop
realli
use
statist
predictor
one
consid
follow
five
procedur
benchmark
dataset
sampl
represent
oper
algorithm
cross
valid
webserv
let
us
describ
deal
onebyon
howev
compli
journal
rubric
style
exactli
follow
aforement
order
exampl
show
advantag
appli
predict
bind
affin
epitopepeptid
class
mhc
molecul
hlaa
hlaa
one
frequent
class
allel
found
mani
differ
speci
popul
play
critic
role
antigen
present
viral
antigen
tumor
antigen
varieti
cancer
express
approxim
caucasian
popul
epitopepeptid
consist
nine
amino
acid
studi
epitopepeptid
nine
side
chain
nine
amino
acid
nine
fragment
eight
physicochem
properti
use
descriptor
natur
amino
acid
four
hmlp
paramet
describ
lipophil
charact
hydrophil
charact
surfac
area
lipophil
potenti
surfac
area
hydrophil
potenti
respect
fifth
properti
volum
amino
acid
side
chain
remain
three
properti
secondari
structur
potenc
indic
amino
acid
coilpot
list
tabl
eight
physicochem
paramet
amino
acid
use
studi
studi
hmlp
paramet
use
describ
lipophil
hydrophil
molecular
fragment
peptid
hmlp
paramet
natur
amino
acid
side
chain
avail
literatur
howev
hmlp
paramet
common
chemic
molecular
fragment
deriv
use
complic
calcul
case
hydrophob
paramet
use
eg
atombas
hydrophob
paramet
reduc
comput
time
cross
valid
studi
perform
via
independ
dataset
test
describ
follow
sequenc
experiment
bind
affin
peptid
use
train
dataset
train
model
peptid
taken
independ
dataset
test
model
actual
peptid
also
compil
seri
public
logarithm
pic
ic
use
bioactiv
relat
chang
free
bind
energi
list
tabl
sequenc
experiment
pic
peptid
use
train
set
bind
strength
train
peptid
test
peptid
cover
low
intermedi
high
affin
follow
two
criteria
appli
choic
test
peptid
rang
bind
affin
test
dataset
exceed
rang
affin
train
set
amino
acid
posit
test
dataset
also
present
posit
train
set
peptid
two
condit
make
peptid
ideal
benchmark
dataset
method
iter
techniqu
describ
method
section
use
bind
affin
studi
peptid
base
sequenc
experiment
data
list
tabl
fragment
paramet
assign
impli
fragment
paramet
equal
import
shown
figur
curv
correl
coeffici
r
vs
iter
curv
r
iter
coeffici
k
curv
r
b
iter
tabl
iter
solut
precedur
correl
coefficien
increas
first
valu
r
converg
valu
r
predict
residu
decreas
first
valu
q
converg
valu
q
predict
pic
queri
peptid
test
set
given
tabl
predict
expect
experiment
data
avail
predict
power
improv
actual
predict
server
human
mhci
peptid
molecul
evalu
review
articl
among
exist
server
rank
first
class
provid
accur
predict
result
mhci
peptid
molecul
correl
coeffici
rang
r
r
shown
studi
predict
correl
coeffici
yield
method
r
rank
around
top
first
class
neither
need
know
exact
comform
peptid
need
align
peptid
accord
templat
two
step
necessari
quit
difficult
comfa
comsia
owe
numer
possibl
conform
peptid
experiment
crystal
structur
serv
templat
often
avail
method
provid
altern
way
design
chemic
drug
peptid
drug
eigenvalu
contribut
physicochem
properti
amino
acid
posit
peptid
summar
tabl
shown
figur
tabl
eigenvalu
normal
eigenvalu
portion
first
three
properti
eigenvector
almost
eigenvalu
portion
first
eigenvector
alon
larger
contribut
made
three
properti
side
chain
volum
vol
lipophil
surfac
area
l
hydrophil
surfac
area
h
molecular
structur
divid
fragment
accord
substitut
investig
fragment
f
f
f
three
substitu
group
fragment
f
remain
part
molecular
parent
b
short
peptid
side
chain
amino
acid
residu
fragment
shown
figur
tabl
contribut
properti
seem
small
eigenvalu
first
peptid
posit
eigenvector
larger
tabl
contribut
nine
amino
acid
posit
differ
howev
differ
big
impli
posit
almost
equal
import
detail
comput
result
given
supplementari
inform
often
face
two
kind
challeng
theoret
predict
drug
design
one
overcorrel
problem
lack
inform
explan
predict
result
overcorrel
problem
caus
larg
amount
paramet
use
predict
model
may
yield
quit
good
correl
result
selfconsist
test
poor
predict
result
independ
dataset
test
owe
high
dimension
disast
curs
dimension
problem
solv
problem
pseudo
amino
acid
composit
pseaac
introduc
ever
sinc
concept
pseaac
gener
pseaac
wide
use
drug
develop
biomedicin
nearli
area
comput
proteom
see
eg
well
long
list
refer
cite
actual
physicochem
properti
use
regard
optim
pseudo
compon
pseaac
approach
remov
trivial
paramet
reduc
featur
vector
dimens
grasp
key
one
besid
tradit
predict
method
fail
provid
good
explan
predict
result
ie
physicochem
properti
structur
chang
affect
bioactiv
contrast
propos
method
provid
inform
impact
physicochem
properti
molecular
fragment
bioactiv
drug
candid
practic
drug
design
develop
usual
basic
structur
drug
candid
keep
constant
small
modif
made
sever
fragment
structur
paramet
entir
molecul
clearli
describ
detail
charact
small
chang
individu
fragment
substitut
model
molecular
structur
separ
sever
fragment
describ
set
fragment
paramet
exampl
molecular
structur
fragment
shown
figur
idea
molecular
fragment
also
appli
peptid
drug
side
chain
amino
acid
fragment
shown
figur
predict
model
bioactiv
w
molecul
summat
contribut
l
molecular
fragment
ie
l
contribut
fragment
l
bioactiv
w
molecul
b
l
predict
coeffici
fragment
l
l
total
number
molecular
fragment
contribut
l
fragment
l
summat
contribut
physicochem
properti
fragment
l
name
x
l
k
physicochem
properti
k
fragment
l
molecul
k
predict
coeffici
physicochem
properti
k
k
total
number
physicochem
properti
insert
get
gener
equat
predict
model
given
n
total
number
molecular
sampl
express
vector
matrix
form
given
x
n
l
k
three
dimension
data
matrix
molecular
paramet
w
n
bioactiv
column
vector
molecular
sampl
b
l
coeffici
vector
fragment
k
coeffici
vector
physicochem
properti
gener
threedimension
equat
reduc
two
equat
follow
algebra
oper
h
n
l
data
matrix
molecular
fragment
substitut
h
n
l
obtain
follow
fragment
equat
likewis
properti
equat
also
express
f
w
f
n
k
data
matrix
physicochem
properti
fragment
equat
properti
equat
solv
use
standard
algebra
method
side
fragment
equat
multipli
transpos
matrix
h
n
l
left
follow
h
w
thu
get
follow
symmetr
squar
matrix
equat
fragment
sinc
fragment
squar
matrix
equat
multipli
invers
matrix
u
l
l
predict
coeffici
b
l
fragment
obtain
given
invers
matrix
u
l
l
obtain
solv
eigen
equat
l
l
eigenvector
l
eigenvalu
fragment
squar
matrix
u
l
l
similarli
leftmultipli
side
properti
equat
f
n
k
get
follow
squar
matrix
equat
properti
multipli
equat
invers
matrix
v
k
k
give
solut
properti
predict
coeffici
k
ie
thu
invers
matrix
v
k
k
obtain
solv
eigen
equat
properti
squar
matrix
v
k
k
k
k
eigenvector
k
eigenvalu
properti
squar
matrix
v
k
k
train
dataset
drug
candid
two
predict
coeffici
set
k
b
l
gener
equat
solv
iter
procedur
firstli
initi
fragment
coeffici
b
l
assign
b
l
impli
fragment
equal
import
initi
b
l
use
properti
equat
eq
l
use
find
k
iter
procedur
repeat
n
time
reach
threshold
valu
ie
illustr
figur
iter
solut
procedur
predictor
properti
eigenvector
k
orthogon
normal
ie
wwwimpactjournalscomoncotarget
k
k
j
k
term
j
k
compon
jth
properti
kth
eigenvector
k
first
properti
eigenvector
princip
compon
whose
eigenvalu
larger
threshold
eg
ie
total
contribut
j
jth
properti
bioactiv
molecular
sampl
train
set
defin
follow
summat
properti
eigenvector
k
span
orthogon
multipl
space
drug
molecul
p
vector
project
j
k
kth
propertyeigenvector
k
calcul
f
ith
row
vector
properti
matrix
f
nk
project
j
k
molecular
sampl
p
kth
propertyeigenvector
j
k
compon
rth
properti
k
r
k
therefor
total
contribut
rth
properti
sampl
p
summat
compon
princip
properti
eigenvector
name
similarli
fragment
eigenvector
l
span
ldimension
orthogon
space
first
fragment
eigenvector
princip
compon
total
contribut
factor
j
jth
fragment
bioactiv
peptid
set
given
way
project
l
sampl
p
lth
fragmenteigenvector
l
calcul
h
ith
row
vector
fragment
matrix
h
nl
project
l
molecul
p
lth
fragmenteigenvector
l
compon
rth
fragment
l
r
l
therefor
total
contribut
rth
fragment
sampl
p
summat
compon
princip
fragment
eigenvector
ie
point
userfriendli
publicli
access
webserv
repres
futur
direct
develop
practic
use
predictor
comput
tool
actual
userfriendli
webserv
given
seri
recent
public
significantli
enhanc
impact
attract
broad
experiment
scientist
best
establish
webserv
soon
possibl
done
announc
made
thorough
public
webpag
predictor
propos
paper
use
tool
drug
design
advantag
summar
follow
molecular
structur
drug
candid
separ
sever
fragment
describ
physicochem
paramet
molecular
fragment
thu
small
modif
individu
fragment
clearli
shown
author
much
indebt
eight
anonym
review
whose
construct
comment
help
strengthen
present
paper
work
support
grant
nation
scienc
foundat
china
nsfc
http
wwwnsfcgovcn
contract
number
guangxi
scienc
technolog
develop
project
